Each box of 10 vials carries a Peptworks label and a unique QR → the batch CoA (HPLC + heavy metals), verified by a third party. Checkable by you and your customers.
🔗 Peptworks.euCJC-1295+Ipamorelin
| Units (combined total) | Discount | €/vial | This product ×100 |
|---|---|---|---|
| 100 | — | €40,00 | €4000 |
| 300 | −18% | €32,80 | €9840 |
| 500 | −25% | €30,00 | €15.000 |
| 1000 | −32% | €27,20 | €27.200 |
Combine any reference: the discount applies to the combined total of vials, not per product. A single tier, not stacked.
What is — CJC-1295+Ipamorelin
CJC-1295 (no DAC) + Ipamorelin is a lyophilized research reagent supplied as a two-component blend in a single vial totalling 10 mg (5 mg + 5 mg). CJC-1295 without DAC is a synthetic growth-hormone-releasing hormone (GHRH) analogue, and Ipamorelin is a selective synthetic growth-hormone secretagogue (a GHRP-class peptide). The blend is intended strictly for in-vitro and preclinical laboratory research (Research Use Only). It is not a medicine, supplement, cosmetic or medical device, and is not for human or animal consumption. Peptworks supplies it to B2B resellers as bulk unbranded vials or as white-label boxed product, from stock held inside the EU.
In laboratory research models, CJC-1295 (no DAC) acts as a GHRH-receptor agonist on pituitary somatotroph cells, while Ipamorelin acts as an agonist at the growth-hormone secretagogue receptor (GHS-R / ghrelin receptor). These two mechanisms are studied together because they engage complementary signalling pathways governing growth-hormone release, a combination frequently used in research to examine potentiated or synergistic secretagogue activity within cell and animal systems. Effects are characterised only within controlled preclinical assays, not in humans.
Research
- Growth-hormone (GH) secretion dynamics in pituitary cell models
- GHRH-receptor and GHS-R (ghrelin receptor) signalling studies
- Comparative and combination growth-hormone secretagogue research
- IGF-1 axis and downstream endocrine signalling in animal models
- Somatotroph function and receptor binding assays
- Peptide stability, formulation and analytical method development
Advantages
- In animal research models, GHRH analogues combined with GHRP-class secretagogues are studied for their potential to elevate pulsatile growth-hormone release relative to either compound alone
- Serves as a reference research reagent for characterising GHRH-receptor and GHS-R co-activation in vitro
- Supports controlled comparison studies of secretagogue potency and receptor selectivity in preclinical settings
- High analytical consistency (≥98% HPLC purity, per-batch CoA) supports reproducibility across laboratory experiments
Safety
- This is a laboratory reagent for research use only, not administered to humans; the following are observations reported in the research literature for this peptide class within experimental models
- Injection-site or local tissue reactions reported in animal-model studies
- Transient changes in glucose-regulation and insulin-related parameters reported in preclinical models
- Water-retention / fluid-balance observations reported in animal research
- Handle as a research chemical: use appropriate PPE, reconstitute and store per laboratory protocol, and keep out of any consumer or clinical use
Ideal for
- B2B resellers sourcing bulk or white-label GH-class research peptides from EU stock
- Research laboratories running growth-hormone secretagogue and receptor-signalling assays
- Comparative preclinical studies of GHRH-analogue plus GHRP combinations
- Analytical / method-development work requiring a documented, per-batch CoA reference reagent
- Distributors needing traceable QR-linked batch documentation for their own customers
This product is a laboratory reagent supplied strictly for research. It is not a medicine, food or supplement and is not for human or veterinary use. It must be handled by qualified professionals under laboratory conditions.
Frequently asked questions
Where can I buy CJC-1295 + Ipamorelin in bulk in the EU?
Peptworks is a B2B wholesale and white-label supplier with the CJC-1295 (no DAC) + Ipamorelin 10 mg (5+5) blend already in stock inside the EU. Orders ship intra-community in 3-5 business days with no customs. The minimum order is 10 units (one box) per reference. It is a Research Use Only reagent and is not sold to end users.
What is the wholesale price per vial of CJC-1295 + Ipamorelin?
Per-vial pricing is public and uses combined-volume discounts on the whole order: EUR 25.00/vial at 100 units, EUR 20.50/vial at 300 units (-18%), EUR 18.75/vial at 500 units (-25%) and EUR 17.00/vial at 1000 units (-32%). The discount is a single tier based on combined total units across the order, not stacked. Payment is in USDC (Polygon or Base).
Can I get CJC-1295 + Ipamorelin white-labelled with my own brand?
Yes. You can order bulk unbranded vials or white-label vials labelled with your own brand and boxed. There is a one-time label setup fee of EUR 180 for orders under 100 units, which is free from 100 units. Each box carries the Peptworks label plus a unique QR that links to that batch's Certificate of Analysis.
What is the minimum order for CJC-1295 + Ipamorelin?
The minimum order is 10 units, which is one box, per reference. Vials ship in boxes of 10. Published per-vial pricing starts at the 100-unit base tier, and the volume discount is set by the combined total units across your whole order.
How is the CJC-1295 + Ipamorelin CoA verified?
Every batch has an independent Certificate of Analysis covering HPLC purity (≥98%) and heavy metals. The box carries a unique QR code that links directly to that batch's CoA, and it can be verified through Peptworks. This gives your customers traceable, per-batch documentation.
How fast is delivery and how do I pay?
Because stock is already inside the EU, orders ship intra-community in 3-5 business days with no customs clearance. Payment is by USDC bank transfer or invoice; there is no card checkout on the site. The full site is available in 10 languages, including English and Spanish.